全文获取类型
收费全文 | 7851篇 |
免费 | 516篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 226篇 |
妇产科学 | 154篇 |
基础医学 | 966篇 |
口腔科学 | 81篇 |
临床医学 | 976篇 |
内科学 | 1478篇 |
皮肤病学 | 58篇 |
神经病学 | 792篇 |
特种医学 | 197篇 |
外科学 | 905篇 |
综合类 | 419篇 |
一般理论 | 5篇 |
预防医学 | 978篇 |
眼科学 | 68篇 |
药学 | 485篇 |
中国医学 | 5篇 |
肿瘤学 | 549篇 |
出版年
2023年 | 62篇 |
2022年 | 84篇 |
2021年 | 197篇 |
2020年 | 125篇 |
2019年 | 195篇 |
2018年 | 229篇 |
2017年 | 156篇 |
2016年 | 170篇 |
2015年 | 206篇 |
2014年 | 323篇 |
2013年 | 398篇 |
2012年 | 573篇 |
2011年 | 680篇 |
2010年 | 314篇 |
2009年 | 279篇 |
2008年 | 596篇 |
2007年 | 563篇 |
2006年 | 519篇 |
2005年 | 486篇 |
2004年 | 466篇 |
2003年 | 382篇 |
2002年 | 368篇 |
2001年 | 110篇 |
2000年 | 89篇 |
1999年 | 99篇 |
1998年 | 76篇 |
1997年 | 58篇 |
1996年 | 49篇 |
1995年 | 46篇 |
1994年 | 29篇 |
1993年 | 16篇 |
1992年 | 47篇 |
1991年 | 33篇 |
1990年 | 33篇 |
1989年 | 29篇 |
1988年 | 26篇 |
1987年 | 19篇 |
1986年 | 16篇 |
1985年 | 23篇 |
1984年 | 24篇 |
1983年 | 13篇 |
1982年 | 11篇 |
1981年 | 10篇 |
1980年 | 10篇 |
1979年 | 9篇 |
1976年 | 9篇 |
1974年 | 11篇 |
1972年 | 9篇 |
1969年 | 8篇 |
1966年 | 9篇 |
排序方式: 共有8374条查询结果,搜索用时 31 毫秒
991.
992.
993.
Tracy M. Mroz Anthony R. Carlini Kristin R. Archer Stephen T. Wegener Jordan I. Hoolachan William Stiers Rebecca A. Shore Renan C. Castillo 《Archives of physical medicine and rehabilitation》2014
Objective
To determine which work-related injuries are the most frequent and costly.Design
Secondary analysis of workers' compensation claims data.Setting
Data were provided by a large, Maryland workers' compensation insurer from 1998 through 2008.Participants
Not applicable.Interventions
None.Main Outcomes Measures
For 45 injury types, the number of claims and compensation amount was calculated for total compensation and for medical and indemnity compensation separately.Results
Back and knee injuries were the most frequently occurring single injury types, whereas heart attack and occupational disease were the most expensive in terms of mean compensation. When taking into account both the frequency and cost of injury (mean cost × number occurrences), back, knee, and shoulder injuries were the most expensive single injury types.Conclusions
Successful prevention and management of back, knee, and shoulder injuries could lead to a substantial reduction in the burden associated with work-related injuries. 相似文献994.
Charles E. Mays Chae Kim Tracy Haldiman Jacques van der Merwe Agnes Lau Jing Yang Jennifer Grams Michele A. Di Bari Romolo Nonno Glenn C. Telling Qingzhong Kong Jan Langeveld Debbie McKenzie David Westaway Jiri G. Safar 《The Journal of clinical investigation》2014,124(2):847-858
The symptoms of prion infection can take years or decades to manifest following the initial exposure. Molecular markers of prion disease include accumulation of the misfolded prion protein (PrPSc), which is derived from its cellular precursor (PrPC), as well as downregulation of the PrP-like Shadoo (Sho) glycoprotein. Given the overlapping cellular environments for PrPC and Sho, we inferred that PrPC levels might also be altered as part of a host response during prion infection. Using rodent models, we found that, in addition to changes in PrPC glycosylation and proteolytic processing, net reductions in PrPC occur in a wide range of prion diseases, including sheep scrapie, human Creutzfeldt-Jakob disease, and cervid chronic wasting disease. The reduction in PrPC results in decreased prion replication, as measured by the protein misfolding cyclic amplification technique for generating PrPSc in vitro. While PrPC downregulation is not discernible in animals with unusually short incubation periods and high PrPC expression, slowly evolving prion infections exhibit downregulation of the PrPC substrate required for new PrPSc synthesis and as a receptor for pathogenic signaling. Our data reveal PrPC downregulation as a previously unappreciated element of disease pathogenesis that defines the extensive, presymptomatic period for many prion strains. 相似文献
995.
Alice Crisp Tracy Dixon Graeme Jones Robert G. Cumming Laura L. Laslett Kuldeep Bhatia Adrian Webster Peter R. Ebeling 《Archives of osteoporosis》2012,7(1-2):179-185
Summary
Between 1997?C1998 and 2006?C2007 in Australia, the age-standardised incidence rates of hip fractures declined by 20 and 13?%, in females and males, respectively. Although this may be related to the rollout of public health campaigns and strategies addressing osteoporosis, absolute numbers of hip fractures continued to increase.Background
Previous reports described an increasing trend in osteoporotic hip fracture incidence in Australia in the 1980s with a stabilisation over the 1990s.Aim
The aim of this study was to describe national trends in the incidence of osteoporotic hip fracture in Australia between 1997?C1998 and 2006?C2007.Methods
Data on low-trauma hip fractures in persons aged 50?years and over were obtained from the National Hospital Morbidity Database. Cases where the patient was transferred in from another hospital were excluded. Age-standardised incidence rates were calculated and a linear test for trend applied.Results
Although the absolute number of hip fracture cases has continued to increase, from 14,769 in 1997?C1998 to 16,412 in 2006?C2007, these numbers are lower than previous predictions based on population ageing. Over the 10-year period, the age-standardised incidence rates in females declined by 20?%, from 370 to 295 per 100,000, while the age-standardised incidence rates in males declined by 13?%, from 200 to 174 per 100,000. Both declines were statistically significant. The sex difference in incidence rates narrowed between 1997?C1998 (females 85?% higher) and 2006?C2007 (females 70?% higher).Conclusions
The age-standardised incidence of osteoporotic hip fracture in Australia is falling. This may be related to the uptake of bisphosphonates as well as the rollout of public health campaigns and strategies addressing osteoporosis. 相似文献996.
997.
998.
Rebecca J. Malott Chia-Hung Wu Tracy D. Lee Trevor J. Hird Nathan F. Dalleska James E. A. Zlosnik Dianne K. Newman David P. Speert 《Antimicrobial agents and chemotherapy》2014,58(9):5211-5219
Burkholderia cepacia complex (Bcc) pulmonary infections in people living with cystic fibrosis (CF) are difficult to treat because of the extreme intrinsic resistance of most isolates to a broad range of antimicrobials. Fosmidomycin is an antibacterial and antiparasitic agent that disrupts the isoprenoid biosynthesis pathway, a precursor to hopanoid biosynthesis. Hopanoids are involved in membrane stability and contribute to polymyxin resistance in Bcc bacteria. Checkerboard MIC assays determined that although isolates of the Bcc species B. multivorans were highly resistant to treatment with fosmidomycin or colistin (polymyxin E), antimicrobial synergy was observed in certain isolates when the antimicrobials were used in combination. Treatment with fosmidomycin decreased the MIC of colistin for isolates as much as 64-fold to as low as 8 μg/ml, a concentration achievable with colistin inhalation therapy. A liquid chromatography-tandem mass spectrometry technique was developed for the accurate quantitative determination of underivatized hopanoids in total lipid extracts, and bacteriohopanetetrol cyclitol ether (BHT-CE) was found to be the dominant hopanoid made by B. multivorans. The amount of BHT-CE made was significantly reduced upon fosmidomycin treatment of the bacteria. Uptake assays with 1-N-phenylnaphthylamine were used to determine that dual treatment with fosmidomycin and colistin increases membrane permeability, while binding assays with boron-dipyrromethene-conjugated polymyxin B illustrated that the addition of fosmidomycin had no impact on polymyxin binding. This work indicates that pharmacological suppression of membrane hopanoids with fosmidomycin treatment can increase the susceptibility of certain clinical B. multivorans isolates to colistin, an agent currently in use to treat pulmonary infections in CF patients. 相似文献
999.
The aim of this article is to understand the components of decision regret for women making breast cancer treatment decisions. Patient-centered care models encourage women to become more active in the decision-making process, inadvertently exposing them to the risk of experiencing decision regret. Enhancing the understanding of the concept of decision regret can offer insight into ways to mitigate this phenomenon. The Walker and Avant method was used to analyze this concept. Using PubMed, CINAHL, ERIC, Academic Search Complete, PsychINFO, SocINDEX, Joanna Briggs Institute of EBP Database, and an online dictionary, articles from 2011 to 2021 were analyzed to identify concept uses, attributes, antecedents, and consequences. Decision regret in women making breast cancer healthcare decisions is a negative cognitive-emotional response to a treatment decision that involves counterfactual thinking with three targets of regret: outcome regret, chosen option regret, and process regret. Experiencing decision regret can reduce a woman's quality of life, inflict psychological distress, and impact future decision-making. Unfavorable outcomes, decision uncertainty, and breakdowns in the decision-making process can lead to decision regret. Findings provide information on identifying women experiencing decision regret and illustrate opportunities to address causative factors through patient education and support to promote optimal patient outcomes. 相似文献